Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Pulse Biosciences (PLSE) Profit After Tax (2021 - 2025)

Historic Profit After Tax for Pulse Biosciences (PLSE) over the last 5 years, with Q3 2025 value amounting to -$19.4 million.

  • Pulse Biosciences' Profit After Tax fell 5287.85% to -$19.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$74.7 million, marking a year-over-year decrease of 6199.47%. This contributed to the annual value of -$53.6 million for FY2024, which is 2694.86% down from last year.
  • As of Q3 2025, Pulse Biosciences' Profit After Tax stood at -$19.4 million, which was down 5287.85% from -$19.2 million recorded in Q2 2025.
  • Pulse Biosciences' 5-year Profit After Tax high stood at -$9.2 million for Q4 2022, and its period low was -$19.4 million during Q4 2024.
  • Its 5-year average for Profit After Tax is -$14.4 million, with a median of -$14.3 million in 2021.
  • In the last 5 years, Pulse Biosciences' Profit After Tax surged by 4325.83% in 2023 and then tumbled by 6839.15% in 2025.
  • Pulse Biosciences' Profit After Tax (Quarter) stood at -$15.4 million in 2021, then skyrocketed by 40.34% to -$9.2 million in 2022, then fell by 29.75% to -$11.9 million in 2023, then tumbled by 62.45% to -$19.4 million in 2024, then changed by 0.0% to -$19.4 million in 2025.
  • Its Profit After Tax stands at -$19.4 million for Q3 2025, versus -$19.2 million for Q2 2025 and -$16.8 million for Q1 2025.